Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Lance B's : Its A Beautiful Thing -- Ignore unavailable to you. Want to Upgrade?

To: LANCE B who wrote (2479)	12/29/1999 2:12:00 PM
From: Harry_Behemoth	Read Replies (1) \| Respond to of 4792

Same here. They keep jumping the price over my offer.

To: LANCE B who wrote (2479)	12/29/1999 3:36:00 PM
From: LANCE B	Respond to of 4792

TNRG- I HAD TO BUY THIS TOO PR NEWSWIRE) TNRG to Spin Off Medical Division Via Rights Offering to Sha TNRG to Spin Off Medical Division Via Rights Offering to Shareholders NEW YORK, Dec. 29 /PRNewswire/ -- Tianrong Building Material Holdings, Ltd. (OTC Bulletin Board: TNRG) announced today that it has selected its Medical Division as its second spin off to shareholders. The spin off will be accomplished by means of a Rights Offering to existing TNRG shareholders. Further details, such as the record date, offering price and share ratio will be announced shortly. TNRG's Medical Division features "The Tracker" a personal computer based electrocardiogram monitor. This battery powered PC-ECG monitor will provide a reliable means to acquire, display, store and print patient's ECG signals through a personal computer. The ECG signals can also be transferred to remote computers by floppy disk or E-mail. It is suited to store a record of a patient's infrequent and elusive ECG events and for general monitoring purpose. The collected data can be used to aid physicians in their diagnosis and treatment of cardiovascular diseases. In early August, the Company filed its premarket notification 510 (K) application. A manufacturer must file this application at least 90 days before the distribution of the medical device in the U.S. market. On November 1, 1999 the FDA contacted the Company and requested additional information on "The Tracker". On November 15, 1999 the Company responded to the FDA's request and submitted an amended 510 (k) application. The Company is currently awaiting a notice of approval from the FDA. The official FDA 510 (K) number is k992584. Tianrong is a business development company that intends to engage in the acquisition of businesses across several sectors and, through the application of its management expertise, to enhance shareholders value. According to the Department of Health & Human Services, cardiovascular diseases (CVD) are the leading cause of death and illness in the United States. Fifty-eight million Americans suffer from one or more types of CVD. The estimated cost of CVD in 1998 in the U.S. alone was $274 billion. James Tilton, President of TNRG stated, "Based on the statistics that we have obtained, it is our belief that the potential market for "The Tracker" is tremendous and with the potential of FDA approval on the horizon it is clear that we are fulfilling our commitment of striving to enhance shareholder value." For further information contact investor relations at 800-324-3464 or visit tnrg.com. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Tianrong Building Material Holdings to accomplish its stated plan of business. Tianrong Building Material believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Tianrong Building Material Holdings or any other person that the objectives and plans of Tianrong Building Material Holdings will be achieved. SOURCE Tianrong Building Material Holdings, Ltd. -0- 12/29/1999 /CONTACT: Tianrong Building Material Holdings, Ltd., investor relations, 800-324-3464/ /Web site: tnrg.com (TNRG) CO: Tianrong Building Material Holdings, Ltd. ST: New York IN: CPR HEA SU: OFR * end of story *